摘要
高血压是抗血管生成药物常见不良反应之一,多为轻、中度。一般通过标准降压治疗即可控制,而严重者可影响患者的抗肿瘤疗效果甚至中断靶向药物治疗。因此,合理选择降压药物对于患者的抗肿瘤治疗具有重要意义。笔者主要探讨抗血管生成药物致高血压的降压药物选择,以期为临床用药提供参考。
Hypertension is a common toxicity of anti-angiogenesis drugs, and mostly expresses as mild or moderate. Generally, it can be controlled by standard antihypertensive treatment. However, the anti-tumor effect of anti-tumor drugs can be affected or even interrupt therapy because of severe hypertension. Therefore, reasonable selection of antihypertensive drugs is of great significance for the treatment of tumor patients. This paper mainly discusses the rational use of drugs in the treatment of hypertension induced by anti- angiogenesis drugs, in order to provide reference for clinical medication.
出处
《临床药物治疗杂志》
2017年第1期59-61,共3页
Clinical Medication Journal
